Drug intelligence / Profile preview

desloratadine

Development stage
Approved
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Desloratadine is a second-generation tricyclic antihistamine used to relieve symptoms of allergic rhinitis (hay fever), chronic idiopathic urticaria (hives), and pruritus. It is the active descarboethoxy metabolite of loratadine. Desloratadine acts as a selective peripheral H1-receptor antagonist, blocking the action of histamine—a substance in the body that causes allergic symptoms such as sneezing, itching, runny nose, watery eyes, and hives. Because it does not readily cross the blood-brain barrier, desloratadine is considered non-sedating compared to first-generation antihistamines. It may also suppress histamine release from human mast cells[3][5][9].

Brand names
ClarinexClarinex ReditabsAeriusAzomyrNeoclaritynDesalex
Other names
Descarboethoxyloratadine8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
02

Targets

HRH1 (Histamine H1 Receptor)CHRM4 (M4)CHRM2 (M2)

Beyond the preview

Go deeper on desloratadine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desloratadine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call